Organigram reports $90M net loss, recreational pot sales to stall until 2021
Organigram (OGI.TO)(OGI) does not expect to show meaningful growth in non-medical cannabis sales until fiscal 2021. The grim projection follows a quarter marked by product write-downs, a wider-than-expected loss, and a missed opportunity to sell larger